🩸🧬Liquid biopsy is transforming cancer detection and monitoring, offering noninvasive insights. Recent studies show that ctDNA levels correlate with outcomes in RCC. Could emerging technologies enhance this? Marc Machaalani Karl Semaan, MD, MSc Marc Eid Rashad Nawfal, MD Razane El Hajj Chehade

Last Call! Abstract submission for #ISLB24 ends tomorrow, September 3 (23:59 CEST). ⏳ Don’t miss your opportunity to contribute to the future of #liquidbiopsy. Submit your research now at 2024.islb.info/b5dv and join leading experts in Denver, Colorado, USA, from November

Channeling their inner champions with the #YusufDikeç pose! 🏸 My precious niece and nephew, are ready to take on the world, one badminton match at a time! #FamilyFun #NextGeneration Yusuf Dikec

Incorporating geriatric assessment into clinical practice is crucial! This workflow helps clinicians evaluate and optimize care for older adults with cancer. A must-read for improving patient outcomes! #GeriOnc #CancerCare OncoAlert Supriya Mohile Young SIOG

Post-Surgery 🧬🧬🧬ctDNA Detection: A Predictor of Relapse in Early Breast Cancer! #liquid #biopsy #DNA ESMO Open linkinghub.elsevier.com/retrieve/pii/S…

This evening Henning Köhne gave a very nice speech and long excellent discussion on metastatic CRC treatment in Ankara. 🚨Most of the recommendations on RAS mutant status and sideness are based on retrospective subgroup analyses DKFZ Klinikum Oldenburg Enes Erul MD Onur Baş, MD Beliz Bahar Karaoğlan

🔍 Current Treatment Options in Metastatic Colorectal Cancer 🧬 🩺 An excellent speech by Claus-Henning Köhne on the latest strategies to improve patient outcomes through targeted therapies and molecular profiling. #ColorectalCancer #Oncology #CancerTreatment TTOD

Enes Erul MD TTOD Erman Akkus Beliz Bahar Karaoğlan Köhne's speech is a game-changer! Highlighting the importance of targeted therapies and molecular profiling to improve patient outcomes is crucial in the fight against metastatic colorectal cancer.

Lorlatinib sets a new standard for ALK+ lung cancer, showing a 96% prevention of brain metastasis! 5-year PFS: 60%. #LungCancer #Oncology OncoAlert Journal of Clinical Oncology Christine Lovly, MD, PhD IASLC doi.org/10.1200/JCO.24…

Meet David Kozono at #ISLB24! David Kozono, MD, PhD, is the Director of Thoracic Radiation Oncology at the Dana-Farber Brigham Cancer Center. He is Study Chair of the NCI ALCHEMIST screening protocol for trials of adjuvant therapies for surgically resected NSCLC, and Chair of

Current Treatment Options in Metastatic Colorectal Cancer by Claus-Henning Köhne - Enes Erul MD TTOD oncodaily.com/blog/138140 #Cancer #MedEd #MedNews #Health #Medicine #MedTwitter #OncoDaily #Oncology

Guardant Health, Inc. - Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy. ⁦International Society of Liquid Biopsy⁩ investors.guardanthealth.com/press-releases…

Dana-Farber Dana-Farber Lank Center for Genitourinary Oncology Toni Choueiri, MD Yüksel Ürün ESMO - Eur. Oncology #ESMO24

📢Exciting News! 🌟 Our Scientific Secretary, Umberto Malapelle , has been recognized by The Pathologist as one of the Hero of Pathology in the world! 🏆👏 His dedication to advancing liquid biopsy research is truly inspiring. Join us in congratulating him on this remarkable

Congratulations on a well-deserved recognition, truly inspiring 👏🏻😌😌 Umberto Malapelle International Society of Liquid Biopsy

Visit our International Society of Liquid Biopsy ISLB booth at #ESMO24 to know the new member opportunities and events! Became a member! #ISLB24 in Denver! M JOSE SERRANO (LB&Cancer Interception group) Umberto Malapelle David Gandara ELO Massimo Cristofanilli, MD, FACP Elsa Anagnostou Charu Aggarwal, MD, MPH, FASCO Nicola Fusco Carolina Reduzzi ESMO - Eur. Oncology

Come visit us at the ISLB booth and learn more about Liquid Biopsy advancements! Join us for ISLB 2024 in Denver and ISLB 2025 in Orlando. Exciting times ahead! #LiquidBiopsy #ESMO24 #oncology ESMO - Eur. Oncology

Join us at #ESMO2024 in Barcelona from September 13-17! Visit our booth #S320 to learn about the latest advancements in liquid biopsies. We can't wait to see you there! #LiquidBiopsies #CancerResearch #ISLB Christian Rolfo M JOSE SERRANO (LB&Cancer Interception group) Umberto Malapelle ELO David Gandara

🌍 Join us at #ESMO2024 in beautiful Barcelona! 🇪🇸 Visit us at Booth S320 in Exhibition Hall 3, Fira Barcelona Gran Via, from September 13-17. We’re excited to offer a free membership for this year to everyone who allows us to scan their badge! Let's explore the latest

Exciting times at #ESMO24 as we explore breakthroughs across multiple cancer types and fields! From targeted therapies to AI and digital oncology, the future of cancer care is here. #oncology #cancer @oncoalert ESMO - Eur. Oncology Andres Cervantes